Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

China Molecular Diagnostics in Cancer Testing Market Research Report 2017

  • QYR1012468
  • 121 Pages
  • February 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Molecular Diagnostics in Cancer Testing

Revenue, means the sales value of Molecular Diagnostics in Cancer Testing

This report studies Molecular Diagnostics in Cancer Testing in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering

Abbott Molecular Diagnostics

Accugenomics

Agendia

Ambry Genetics

Biodesix

bioMerieux

bioTheranostics (AviaraDx)

Cancer Genetics

Clarient, Inc. (GE Healthcare)

Counsyl

Flatiron Health

Epigenomics

Exact Sciences Corporation

Exiqon

Genomic Health

Genoptix (Novartis)

Genmark Diagnostics

Genomictree

HTG Molecular Diagnostics

Invitae

LabCorp

Myriad Genetics

Nanostring

Neogenomics

NSTG

Nuvera Biosciences

Orion Genomics

Pathway Genomics

Market Segment by Regions (provinces), covering

South China

East China

Southwest China

Northeast China

North China

Central China

Northwest China

Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Split by Application, this report focuses on consumption, market share and growth rate of Molecular Diagnostics in Cancer Testing in each application, can be divided into

Application 1

Application 2

Table of Contents

China Molecular Diagnostics in Cancer Testing Market Research Report 2017

1 Molecular Diagnostics in Cancer Testing Market Overview

1.1 Product Overview and Scope of Molecular Diagnostics in Cancer Testing

1.2 Molecular Diagnostics in Cancer Testing Segment by Type

1.2.1 China Production Market Share of Molecular Diagnostics in Cancer Testing Type in 2015

1.2.2 Type I

1.2.3 Type II

1.3 Applications of Molecular Diagnostics in Cancer Testing

1.3.1 Molecular Diagnostics in Cancer Testing Consumption Market Share by Application in 2015

1.3.2 Application 1

1.3.3 Application 2

1.4 China Market Size (Value) of Molecular Diagnostics in Cancer Testing (2012-2022)

1.5 China Molecular Diagnostics in Cancer Testing Status and Outlook

1.6 Government Policies

2 China Molecular Diagnostics in Cancer Testing Market Competition by Manufacturers

2.1 China Molecular Diagnostics in Cancer Testing Capacity, Production and Share by Manufacturers (2015 and 2016)

2.2 China Molecular Diagnostics in Cancer Testing Revenue and Share by Manufacturers (2015 and 2016)

2.3 China Molecular Diagnostics in Cancer Testing Average Price by Manufacturers (2015 and 2016)

2.4 Manufacturers Molecular Diagnostics in Cancer Testing Manufacturing Base Distribution, Sales Area, Product Type

2.5 Molecular Diagnostics in Cancer Testing Market Competitive Situation and Trends

2.5.1 Molecular Diagnostics in Cancer Testing Market Concentration Rate

2.5.2 Molecular Diagnostics in Cancer Testing Market Share of Top 3 and Top 5 Manufacturers

3 China Molecular Diagnostics in Cancer Testing Manufacturers Profiles/Analysis

3.1 Abbott Molecular Diagnostics

3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.1.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification

3.1.2.1 Product A

3.1.2.2 Product B

3.1.3 Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.1.4 Main Business/Business Overview

3.2 Accugenomics

3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.2.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification

3.2.2.1 Product A

3.2.2.2 Product B

3.2.3 Accugenomics Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.2.4 Main Business/Business Overview

3.3 Agendia

3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.3.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification

3.3.2.1 Product A

3.3.2.2 Product B

3.3.3 Agendia Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.3.4 Main Business/Business Overview

3.4 Ambry Genetics

3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.4.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification

3.4.2.1 Product A

3.4.2.2 Product B

3.4.3 Ambry Genetics Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.4.4 Main Business/Business Overview

3.5 Biodesix

3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.5.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification

3.5.2.1 Product A

3.5.2.2 Product B

3.5.3 Biodesix Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.5.4 Main Business/Business Overview

3.6 bioMerieux

3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.6.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification

3.6.2.1 Product A

3.6.2.2 Product B

3.6.3 bioMerieux Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.6.4 Main Business/Business Overview

3.7 bioTheranostics (AviaraDx)

3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.7.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification

3.7.2.1 Product A

3.7.2.2 Product B

3.7.3 bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.7.4 Main Business/Business Overview

3.8 Cancer Genetics

3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.8.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification

3.8.2.1 Product A

3.8.2.2 Product B

3.8.3 Cancer Genetics Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.8.4 Main Business/Business Overview

3.9 Clarient, Inc. (GE Healthcare)

3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.9.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification

3.9.2.1 Product A

3.9.2.2 Product B

3.9.3 Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.9.4 Main Business/Business Overview

3.10 Counsyl

3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.10.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification

3.10.2.1 Product A

3.10.2.2 Product B

3.10.3 Counsyl Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.10.4 Main Business/Business Overview

3.11 Flatiron Health

3.12 Epigenomics

3.13 Exact Sciences Corporation

3.14 Exiqon

3.15 Genomic Health

3.16 Genoptix (Novartis)

3.17 Genmark Diagnostics

3.18 Genomictree

3.19 HTG Molecular Diagnostics

3.20 Invitae

3.21 LabCorp

3.22 Myriad Genetics

3.23 Nanostring

3.24 Neogenomics

3.25 NSTG

3.26 Nuvera Biosciences

3.27 Orion Genomics

3.28 Pathway Genomics

4 China Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)

4.1 China Molecular Diagnostics in Cancer Testing Capacity, Production and Growth (2012-2017)

4.2 China Molecular Diagnostics in Cancer Testing Revenue and Growth (2012-2017)

4.3 China Molecular Diagnostics in Cancer Testing Production, Consumption, Export and Import (2012-2017)

5 China Molecular Diagnostics in Cancer Testing Production, Revenue (Value), Price Trend by Type

5.1 China Molecular Diagnostics in Cancer Testing Production and Market Share by Type (2012-2017)

5.2 China Molecular Diagnostics in Cancer Testing Revenue and Market Share by Type (2012-2017)

5.3 China Molecular Diagnostics in Cancer Testing Price by Type (2012-2017)

5.4 China Molecular Diagnostics in Cancer Testing Production Growth by Type (2012-2017)

6 China Molecular Diagnostics in Cancer Testing Market Analysis by Application

6.1 China Molecular Diagnostics in Cancer Testing Consumption and Market Share by Application (2012-2017)

6.2 China Molecular Diagnostics in Cancer Testing Consumption Growth Rate by Application (2012-2017)

6.3 Market Drivers and Opportunities

6.3.1 Potential Application

6.3.2 Emerging Markets/Countries

7 ChinaMolecular Diagnostics in Cancer Testing Market Analysis by Regions (Provinces)

7.1 China Molecular Diagnostics in Cancer Testing Production, Production Value and Price by Regions (Provinces)(2012-2017)

7.1.1 China Molecular Diagnostics in Cancer Testing Production and Market Share by Regions (Provinces)(2012-2017)

7.1.2 China Molecular Diagnostics in Cancer Testing Production Value and Market Share by Regions (Provinces)(2012-2017)

7.1.3 China Molecular Diagnostics in Cancer Testing Sales Price by Regions (Provinces)(2012-2017)

7.2 China Molecular Diagnostics in Cancer Testing Consumption by Regions (Provinces)(2012-2017)

7.3 China Molecular Diagnostics in Cancer Testing Production, Consumption, Export and Import (2012-2017)

8 Molecular Diagnostics in Cancer Testing Manufacturing Cost Analysis

8.1 Molecular Diagnostics in Cancer Testing Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of Molecular Diagnostics in Cancer Testing

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Molecular Diagnostics in Cancer Testing Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Molecular Diagnostics in Cancer Testing Major Manufacturers in 2015

9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

12 China Molecular Diagnostics in Cancer Testing Market Forecast (2017-2022)

12.1 China Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue Forecast (2017-2022)

12.2 China Molecular Diagnostics in Cancer Testing Production, Import, Export and Consumption Forecast (2017-2022)

12.3 China Molecular Diagnostics in Cancer Testing Production Forecast by Type (2017-2022)

12.4 China Molecular Diagnostics in Cancer Testing Consumption Forecast by Application (2017-2022)

12.5 China Molecular Diagnostics in Cancer Testing Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)

12.5.1 China Molecular Diagnostics in Cancer Testing Production Forecast by Regions (Provinces)(2017-2022)

12.5.2 China Molecular Diagnostics in Cancer Testing Consumption Forecast by Regions (Provinces)(2017-2022)

12.5.3 China Molecular Diagnostics in Cancer Testing Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)

12.6 Molecular Diagnostics in Cancer Testing Price Forecast (2017-2022)

13 Research Findings and Conclusion

14 Appendix

Methodology

Analyst Introduction

Data Source

List of Tables and Figures

Figure Picture of Molecular Diagnostics in Cancer Testing

Figure China Production Market Share of Molecular Diagnostics in Cancer Testing by Type in 2015

Figure Product Picture of Type I

Table Major Manufacturers of Type I

Figure Product Picture of Type II

Table Major Manufacturers of Type II

Table Molecular Diagnostics in Cancer Testing Consumption Market Share by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure China Molecular Diagnostics in Cancer Testing Revenue (Million USD) and Growth Rate (2012-2022)

Table China Molecular Diagnostics in Cancer Testing Capacity of Key Manufacturers (2015 and 2016)

Table China Molecular Diagnostics in Cancer Testing Capacity Market Share of Key Manufacturers (2015 and 2016)

Figure China Molecular Diagnostics in Cancer Testing Capacity of Key Manufacturers in 2015

Figure China Molecular Diagnostics in Cancer Testing Capacity of Key Manufacturers in 2016

Table China Molecular Diagnostics in Cancer Testing Production of Key Manufacturers (2015 and 2016)

Table China Molecular Diagnostics in Cancer Testing Production Share by Manufacturers (2015 and 2016)

Figure 2015 Molecular Diagnostics in Cancer Testing Production Share by Manufacturers

Figure 2016 Molecular Diagnostics in Cancer Testing Production Share by Manufacturers

Table China Molecular Diagnostics in Cancer Testing Revenue (Million USD) by Manufacturers (2015 and 2016)

Table China Molecular Diagnostics in Cancer Testing Revenue Share by Manufacturers (2015 and 2016)

Table 2015 China Molecular Diagnostics in Cancer Testing Revenue Share by Manufacturers

Table 2016 China Molecular Diagnostics in Cancer Testing Revenue Share by Manufacturers

Table China Market Molecular Diagnostics in Cancer Testing Average Price of Key Manufacturers (2015 and 2016)

Figure China Market Molecular Diagnostics in Cancer Testing Average Price of Key Manufacturers in 2015

Table Manufacturers Molecular Diagnostics in Cancer Testing Manufacturing Base Distribution and Sales Area

Table Manufacturers Molecular Diagnostics in Cancer Testing Product Type

Figure Molecular Diagnostics in Cancer Testing Market Share of Top 3 Manufacturers

Figure Molecular Diagnostics in Cancer Testing Market Share of Top 5 Manufacturers

Table Abbott Molecular Diagnostics Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Market Share (2012-2017)

Table Accugenomics Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Accugenomics Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Accugenomics Molecular Diagnostics in Cancer Testing Market Share (2012-2017)

Table Agendia Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Agendia Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Agendia Molecular Diagnostics in Cancer Testing Market Share (2012-2017)

Table Ambry Genetics Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Ambry Genetics Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Ambry Genetics Molecular Diagnostics in Cancer Testing Market Share (2012-2017)

Table Biodesix Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Biodesix Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Biodesix Molecular Diagnostics in Cancer Testing Market Share (2012-2017)

Table bioMerieux Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table bioMerieux Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure bioMerieux Molecular Diagnostics in Cancer Testing Market Share (2012-2017)

Table bioTheranostics (AviaraDx) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Market Share (2012-2017)

Table Cancer Genetics Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Cancer Genetics Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Cancer Genetics Molecular Diagnostics in Cancer Testing Market Share (2012-2017)

Table Clarient, Inc. (GE Healthcare) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing Market Share (2012-2017)

Table Counsyl Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Counsyl Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Counsyl Molecular Diagnostics in Cancer Testing Market Share (2012-2017)

Table Flatiron Health Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Epigenomics Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Exact Sciences Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Exiqon Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Genomic Health Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Genoptix (Novartis) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Genmark Diagnostics Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Genomictree Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table HTG Molecular Diagnostics Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Invitae Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table LabCorp Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Myriad Genetics Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Nanostring Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Neogenomics Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table NSTG Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Nuvera Biosciences Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Orion Genomics Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Pathway Genomics Basic Information, Manufacturing Base, Sales Area and Its Competitors

Figure China Molecular Diagnostics in Cancer Testing Capacity, Production and Growth (2012-2017)

Figure China Molecular Diagnostics in Cancer Testing Revenue (Million USD) and Growth (2012-2017)

Table China Molecular Diagnostics in Cancer Testing Production, Consumption, Export and Import (2012-2017)

Table China Molecular Diagnostics in Cancer Testing Production by Type (2012-2017)

Table China Molecular Diagnostics in Cancer Testing Production Share by Type (2012-2017)

Figure Production Market Share of Molecular Diagnostics in Cancer Testing by Type (2012-2017)

Figure 2015 Production Market Share of Molecular Diagnostics in Cancer Testing by Type

Table China Molecular Diagnostics in Cancer Testing Revenue by Type (2012-2017)

Table China Molecular Diagnostics in Cancer Testing Revenue Share by Type (2012-2017)

Figure Production Revenue Share of Molecular Diagnostics in Cancer Testing by Type (2012-2017)

Figure 2015 Revenue Market Share of Molecular Diagnostics in Cancer Testing by Type

Table China Molecular Diagnostics in Cancer Testing Price by Type (2012-2017)

Figure China Molecular Diagnostics in Cancer Testing Production Growth by Type (2012-2017)

Table China Molecular Diagnostics in Cancer Testing Consumption by Application (2012-2017)

Table China Molecular Diagnostics in Cancer Testing Consumption Market Share by Application (2012-2017)

Figure China Molecular Diagnostics in Cancer Testing Consumption Market Share by Application in 2015

Table China Molecular Diagnostics in Cancer Testing Consumption Growth Rate by Application (2012-2017)

Figure China Molecular Diagnostics in Cancer Testing Consumption Growth Rate by Application (2012-2017)

Table China Molecular Diagnostics in Cancer Testing Production by Regions (Provinces)(2012-2017)

Table China Molecular Diagnostics in Cancer Testing Production Market Share by Regions (Provinces)(2012-2017)

Table China Molecular Diagnostics in Cancer Testing Production Value by Regions (Provinces)(2012-2017)

Table China Molecular Diagnostics in Cancer Testing Production Value Market Share by Regions (Provinces)(2012-2017)

Table China Molecular Diagnostics in Cancer Testing Sales Price by Regions (Provinces)(2012-2017)

Table China Molecular Diagnostics in Cancer Testing Consumption by Regions (Provinces)(2012-2017)

Table China Molecular Diagnostics in Cancer Testing Consumption Market Share by Regions (Provinces)(2012-2017)

Table China Molecular Diagnostics in Cancer Testing Production, Consumption, Export and Import (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Molecular Diagnostics in Cancer Testing

Figure Manufacturing Process Analysis of Molecular Diagnostics in Cancer Testing

Figure Molecular Diagnostics in Cancer Testing Industrial Chain Analysis

Table Raw Materials Sources of Molecular Diagnostics in Cancer Testing Major Manufacturers in 2015

Table Major Buyers of Molecular Diagnostics in Cancer Testing

Table Distributors/Traders List

Figure China Molecular Diagnostics in Cancer Testing Capacity, Production and Growth Rate Forecast (2017-2022)

Figure China Molecular Diagnostics in Cancer Testing Revenue and Growth Rate Forecast (2017-2022)

Table China Molecular Diagnostics in Cancer Testing Production, Import, Export and Consumption Forecast (2017-2022)

Table China Molecular Diagnostics in Cancer Testing Production Forecast by Type (2017-2022)

Table China Molecular Diagnostics in Cancer Testing Consumption Forecast by Application (2017-2022)

Table China Molecular Diagnostics in Cancer Testing Production Forecast by Regions (Provinces)(2017-2022)

Table China Molecular Diagnostics in Cancer Testing Consumption Forecast by Regions (Provinces)(2017-2022)

Table China Molecular Diagnostics in Cancer Testing Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370